GlassScriptPhysician profile
Stacey D Pappas
NPI 1205250560
$2,390.81
in general payments reported to CMS, 2019-2025
24 companies · $466 in 2025
The $466 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $821 · 2022: $91.68 · 2023: $360 · 2024: $651 · 2025: $466.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,378 · Education: $99.98.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,377.96 |
| Education | $99.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $581.48 | 2021-2025 | |
| Regeneron Healthcare Solutions, INC. | $417.15 | 2022-2025 | Dupixent |
| Inspire Medical Systems, INC. | $311.46 | 2023-2025 | Inspire |
| Medtronic, INC. | $260.83 | 2021-2025 | Propel |
| Glaxosmithkline, LLC. | $147.22 | 2024-2025 | Nucala |
| Sanofi-Aventis U.S. LLC | $99.98 | 2023-2025 | |
| Collegium Pharmaceutical, INC. | $73.19 | 2021 | |
| Abbvie INC. | $64.98 | 2021 | |
| Allergan, INC. | $52.06 | 2021 | |
| Arbor Pharmaceuticals, INC. | $44.20 | 2021 | |
| Virtus Pharmaceuticals LLC | $43.21 | 2021 | |
| Abbott Laboratories | $40.47 | 2021 | |
| Almatica Pharma LLC | $33.13 | 2021 | |
| Optinose US, INC. | $29.58 | 2024 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $29.19 | 2021 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $24.10 | 2021 | |
| Organogenesis INC. | $23.96 | 2022 | |
| Stryker Corporation | $22.28 | 2025 | Latera |
| Solventum Corporation | $19.74 | 2024 | V.A.C. Veraflo Cleanse Choice |
| Scilex Pharmaceuticals INC. | $18.88 | 2021 | |
| Pfizer INC. | $16.00 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $13.56 | 2021 | |
| Biodelivery Sciences International, INC. | $12.79 | 2021 | |
| Redhill Biopharma INC. | $11.37 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stacey Pappas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.